You have 9 free searches left this month | for more free features.

Phase 1/2

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)

Not yet recruiting
  • Facio-Scapulo-Humeral Dystrophy
  • ARO-DUX4 for Injection
  • Placebo
  • (no location specified)
Nov 13, 2023

Amyotrophic Lateral Sclerosis Trial (AMT-162)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Oct 20, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)

Not yet recruiting
  • Anaphylactic Reaction
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Aug 22, 2023

Solid Tumor Trial in Sydney (IBI129)

Not yet recruiting
  • Solid Tumor
  • Sydney, New South Wales, Austria
    St George private Hospital
Aug 6, 2023

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

Advanced Solid Tumor Trial (7MW3711 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • 7MW3711 for injection
  • (no location specified)
Aug 18, 2023

Pancreatic Cancer Trial (PBP1510 (400mg/16mL), Gemcitabine (1000 mg/m^2))

Not yet recruiting
  • Pancreatic Cancer
  • PBP1510 (400mg/16mL)
  • Gemcitabine (1000 mg/m^2)
  • (no location specified)
Sep 27, 2022

COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

Active, not recruiting
  • COVID-19
  • +2 more
  • VB10.2129
  • VB10.2210
  • Bergen, Norway
  • +1 more
Jan 6, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

Not yet recruiting
  • Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2023

Advanced Gastrointestinal Tumors Trial in Shanghai (Donafenib Tosilate Tablets, KN046 Injection)

Recruiting
  • Advanced Gastrointestinal Tumors
  • Donafenib Tosilate Tablets
  • KN046 Injection
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Nov 28, 2022

Advanced Prostate Cancer Trial (HRS-4357 injection)

Not yet recruiting
  • Advanced Prostate Cancer
  • HRS-4357 injection
  • (no location specified)
Aug 16, 2023

Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)

Recruiting
  • Advanced Solid Tumor
  • YL201 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 21, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
May 26, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jun 15, 2023

Advanced Solid Tumor Trial in Brussels (GTAEXS617)

Recruiting
  • Advanced Solid Tumor
  • Brussels, Belgium
    Clinique Universitaires Saint-Luc
Aug 8, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Melanoma Metastatic in the Brain Trial in Gainesville (CA-4948, Pembrolizumab)

Not yet recruiting
  • Melanoma Metastatic in the Brain
  • Gainesville, Florida
    University of Florida
Dec 20, 2022